{"disease":{"id":"scleroderma-diffuse","name":"scleroderma diffuse"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06772896","title":"Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":851,"lead_sponsor_name":"Lady Davis Institute","has_results":false},{"nct_id":"NCT05168215","title":"Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Elpen Pharmaceutical Co. Inc.","has_results":false},{"nct_id":"NCT05148598","title":"ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":174,"lead_sponsor_name":"Paracrine, INC.","has_results":false},{"nct_id":"NCT05622578","title":"Phenotyping of Chronic Pain in Diffused Systemic Scleroderma","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06655896","title":"Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04464434","title":"Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT07292961","title":"Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT06425653","title":"Exercise With Scleroderma Functional Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Trakya University","has_results":false},{"nct_id":"NCT04647890","title":"Effects of FT011 in Systemic Sclerosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Certa Therapeutics","has_results":true},{"nct_id":"NCT06684132","title":"Respiratory Muscle Training in Scleroderma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Firat University","has_results":false},{"nct_id":"NCT05351060","title":"Novel Splinting Technique Using 3D Models","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Giovanna Fichera","has_results":false},{"nct_id":"NCT03831438","title":"Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT04837131","title":"A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Michael M. Pham","has_results":true}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}